Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:10 pm Purchase |
2024-12-31 | 13G | Insmed Incorporated INSM |
Darwin Global Management, Ltd. | 12,960,538 7.200% |
3,242,716 (+33.37%) |
Filing History |
| 2024-11-14 7:45 pm Sale |
2024-09-30 | 13G | TG Therapeutics, Inc. TGTX |
Darwin Global Management, Ltd. | 0 0.000% |
-4,046,598 (Position Closed) |
Filing History |
| 2024-09-03 5:22 pm Purchase |
2024-08-23 | 13G | Insmed Incorporated INSM |
Darwin Global Management, Ltd. | 9,717,822 5.700% |
9,717,822 (New Position) |
Filing History |
| 2024-02-14 3:30 pm Sale |
2023-12-31 | 13G | TG Therapeutics, Inc. TGTX |
Darwin Global Management, Ltd. | 4,046,598 2.700% |
-6,404,643 (-61.28%) |
Filing History |
| 2023-06-28 4:45 pm Purchase |
2023-06-27 | 13D | Ambrx Biopharma Inc. AMAM |
Darwin Global Management, Ltd. | 116,820,452 27.500% |
37,688,441 (+47.63%) |
Filing History |
| 2023-05-25 4:39 pm Unchanged |
2023-05-23 | 13D | Ambrx Biopharma Inc. AMAM |
Darwin Global Management, Ltd. | 79,132,011 20.500% |
0 (Unchanged) |
Filing History |
| 2023-04-03 08:00 am Purchase |
2023-03-22 | 13G | TG Therapeutics, Inc. TGTX |
Darwin Global Management, Ltd. | 10,451,241 7.100% |
10,451,241 (New Position) |
Filing History |
| 2023-03-08 10:49 am Purchase |
2023-03-06 | 13D | Ambrx Biopharma Inc. AMAM |
Darwin Global Management, Ltd. | 79,132,011 26.400% |
26,040,588 (+49.05%) |
Filing History |
| 2023-02-14 09:30 am Purchase |
2022-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Darwin Global Management, Ltd. | 53,091,423 19.600% |
2,450,000 (+4.84%) |
Filing History |
| 2022-12-19 08:30 am Purchase |
2022-12-09 | 13G | Ambrx Biopharma Inc. AMAM |
Darwin Global Management, Ltd. | 50,641,423 18.700% |
50,641,423 (New Position) |
Filing History |